If you need more lookups,
subscriptions start at $34 USD/month.
Daniel Matlis Location
Philadelphia, PA, US
Daniel Matlis Work
2005 -now President @
2020 -now in Silico Clinical Trials Advisory Council Member @
1997 -2005 Vice President and General Manager @ Stelex Inc.
1990 -1997 Group Leader - Computer Integrated Manufacturing, Technical Owner - Computer System Validation @
Daniel Matlis Education
Polytechnic University
BS (Electrical Engineering)
1989-1991
Escuela Nacional de Education Technica 28, Buenos Aires, Argentina
(Electronica)
1981-1985
New Jersey Institute of Technology
Daniel Matlis Skills
Medical Devices
Biotechnology
Diagnostics
FDA
Pharmaceuticals
Life Sciences
Technology Transfer
Regulatory Affairs
Quality Management
Quality Systems
Healthcare
Compliance
21 CFR Part 11
GMP
Process Improvement
Cross-functional Team Leadership
Business Process Improvement
cGMP
Validation
Business Strategy
Lifesciences
Supply Chain Management
Global Sourcing
Outsourcing
Strategic Planning
SDLC
Hardware Diagnostics
R&D
Strategy
ISO 13485
Six Sigma
Manufacturing
Leadership
Quality System
Business Development
Product Development
Quality Assurance
Pharmaceutical Industry
Product Launch
Change Control
Pharmaceutics
V&V
Quality Auditing
Process Simulation
Regulatory Requirements
CAPA
Sop
Clinical Development
Process Engineering
Cross Functional Team Leadership
u.s. Food and Drug Administration Fda
Marketing
Microsoft Office
Research
Management
Social Media
u.s. Food and Drug Administration
Daniel Matlis Summary
Daniel Matlis, based in Philadelphia, PA, US, is currently a President at Axendia, Inc.. Daniel Matlis brings experience from previous roles at FDA, Stelex Inc. and Johnson & Johnson. Daniel Matlis holds a 1989 - 1991 BS in Electrical Engineering @ Polytechnic University. With a robust skill set that includes Medical Devices, Biotechnology, Diagnostics, FDA, Pharmaceuticals and more. Daniel Matlis has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Daniel Matlis?
Find contact details for 700 million professionals.